Supplementary Figure S2 from Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)

<p>Hepatic partial RECIST response to sirolimus as a first-line therapy in a man with visceral PEComa. Panel A shows the baseline CT scan; panel B shows the partial RECIST response after 2 months of treatment. Red arrows indicate a liver metastasis.</p>